middle.news
Dimerix Secures AU$4.2M Milestone as Japan Trial Advances
8:52am on Monday 30th of June, 2025 AEST
•
Healthcare
Read Story
Dimerix Secures AU$4.2M Milestone as Japan Trial Advances
8:52am on Monday 30th of June, 2025 AEST
Key Points
First development milestone payment of ¥400 million (~AU$4.2 million) received from FUSO
Clinical sites opened in Japan to support ACTION3 Phase 3 trial recruitment
FUSO licensing deal is one of four regional agreements for DMX-200
Potential total milestone payments and royalties from FUSO could reach ~AU$107 million
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Dimerix (ASX:DXB)
OPEN ARTICLE